Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 20;15(1):85.
doi: 10.1186/s13578-025-01418-6.

Programmed cell death in the cognitive impairment of obstructive sleep apnea

Affiliations
Review

Programmed cell death in the cognitive impairment of obstructive sleep apnea

Yanru Ou et al. Cell Biosci. .

Abstract

Cognitive impairment (CI) is a significant and extraordinary complication of obstructive sleep apnea (OSA) patients. Programmed cell death (PCD) is an active and ordered process regulated by genes. A growing number of studies find that PCD is responsible for cognitive dysfunction and plays an important role in various neurological diseases, which involve apoptosis, necroptosis, pyroptosis, ferroptosis, and cell death associated with autophagy. However, the influence of PCD on OSA-CI remains unclear. We summarized the relevant studies that discussed the involvement of PCD in the CI of OSA and aimed to clarify the underlying mechanisms. Intermittent hypoxia (IH)-induced PCD had a critical effect on the mechanisms that produced the ultimate neurological deficit in OSA, and the PCD involved mainly included apoptosis, autophagy, ferroptosis, and pyroptosis. IH regulates PCD directly or through specific pathways, and drugs targeting related molecules have the potential to improve cognitive function. These findings enrich the pathogenesis of OSA-CI and provide new therapeutic insights.

Keywords: Cognitive impairment; Intermittent hypoxia; Obstructive sleep apnea; Programmed cell death.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Regulatory pathways or evidence of programmed cell death in OSA-CI
Fig. 2
Fig. 2
Possible treatments for OSA-CI

Similar articles

References

    1. Chang JL, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2023;13:1061–482. 10.1002/alr.23079. - PMC - PubMed
    1. Meliante PG, et al. Molecular pathology, oxidative stress, and biomarkers in obstructive sleep apnea. Int J Mol Sci. 2023;24:5478. 10.3390/ijms24065478. - PMC - PubMed
    1. Benjafield AV, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98. 10.1016/S2213-2600(19)30198-5. - PMC - PubMed
    1. Lv R, et al. Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. Signal Transduct Target Ther. 2023;8:218. 10.1038/s41392-023-01496-3. - PMC - PubMed
    1. Pase MP, et al. Sleep architecture, obstructive sleep apnea, and cognitive function in adults. JAMA Netw Open. 2023;6:e2325152. 10.1001/jamanetworkopen.2023.25152. - PMC - PubMed

LinkOut - more resources